CI	confidence interval
CNV	copy number variation
CR	complete response
CRC	colorectal cancer
ctDNA	circulating tumor DNA
DCR	disease control rate
dMMR	mismatch repair deficiency
ECOG	Eastern Cooperative Oncology Group
ESMO	European Society for Medical Oncology
FFPE	formalin-fixed paraffin-embedded
FOLFOX	folinic acid (leucovorin, FOL), fluorouracil (5-FU, F), and oxaliplatin (Eloxatin, OX)
HR	hazard ratio
ICI	immune checkpoint inhibitor
IHC	immunohistochemistry
ITT	intention-to-treat (population)
LB	liquid biopsy
MSI	microsatellite instability
NGS	next-generation sequencing
ORR	objective response rate
PCR	polymerase chain reaction
PD	progressive disease
PFS	progression-free survival
PR	partial response
SD	stable disease
STR	short tandem repeats